|
1
|
Severino P, Alvares AM, Michaluart P Jr,
Okamoto OK, Nunes FD, Moreira-Filho CA and Tajara EH; Head and Neck
Genome Project GENCAPO. Global gene expression profiling of oral
cavity cancers suggests molecular heterogeneity within anatomic
subsites. BMC Res Notes. 1:1132008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yao M, Epstein JB, Modi BJ, Pytynia KB,
Mundt AJ and Feldman LE: Current surgical treatment of squamous
cell carcinoma of the head and neck. Oral Oncol. 43:213–223. 2007.
View Article : Google Scholar
|
|
3
|
Casiglia J and Woo SB: A comprehensive
review of oral cancer. Gen Dent. 49:72–82. 2001.
|
|
4
|
Takes RP: Staging of the neck in patients
with head and neck squamous cell cancer: Imaging techniques and
biomarkers. Oral Oncol. 40:656–667. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karatzanis AD, Waldfahrer F, Psychogios G,
Hornung J, Zenk J, Velegrakis GA and Iro H: Resection margins and
other prognostic factors regarding surgically treated glottic
carcinomas. J Surg Oncol. 101:131–136. 2010.
|
|
6
|
Fan S, Tang QL, Lin YJ, Chen WL, Li JS,
Huang ZQ, Yang ZH, Wang YY, Zhang DM, Wang HJ, et al: A review of
clinical and histological parameters associated with contralateral
neck metastases in oral squamous cell carcinoma. Int J Oral Sci.
3:180–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lea J, Bachar G, Sawka AM, Lakra DC,
Gilbert RW, Irish JC, Brown DH, Gullane PJ and Goldstein DP:
Metastases to level IIb in squamous cell carcinoma of the oral
cavity: A systematic review and meta-analysis. Head Neck.
32:184–190. 2010.
|
|
8
|
Okura M, Aikawa T, Sawai NY, Iida S and
Kogo M: Decision analysis and treatment threshold in a management
for the N0 neck of the oral cavity carcinoma. Oral Oncol.
45:908–911. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Greenberg JS, Fowler R, Gomez J, Mo V,
Roberts D, El Naggar AK and Myers JN: Extent of extracapsular
spread: A critical prognosticator in oral tongue cancer. Cancer.
97:1464–1470. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanaka J, Irié T, Yamamoto G, Yasuhara R,
Isobe T, Hokazono C, Tachikawa T, Kohno Y and Mishima K: ANGPTL4
regulates the metastatic potential of oral squamous cell carcinoma.
J Oral Pathol Med. 44:126–133. 2015. View Article : Google Scholar
|
|
12
|
Lewis RA, Yamashiro S, Gokhin DS and
Fowler VM: Functional effects of mutations in the
tropomyosin-binding sites of tropomodulin1 and tropomodulin3.
Cytoskeleton Hoboken. 71:395–411. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bliss KT, Tsukada T, Novak SM, Dorovkov
MV, Shah SP, Nworu C, Kostyukova AS and Gregorio CC:
Phosphorylation of tropomodulin1 contributes to the regulation of
actin filament architecture in cardiac muscle. FASEB J.
28:3987–3995. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Krieger I, Kostyukova A, Yamashita A,
Nitanai Y and Maéda Y: Crystal structure of the C-terminal half of
tropomodulin and structural basis of actin filament pointed-end
capping. Biophys J. 83:2716–2725. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kostyukova A, Maeda K, Yamauchi E, Krieger
I and Maéda Y: Domain structure of tropomodulin: Distinct
properties of the N-terminal and C-terminal halves. Eur J Biochem.
267:6470–6475. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kostyukova AS: Tropomodulins and
tropomodulin/tropomyosin interactions. Cell Mol Life Sci.
65:563–569. 2008. View Article : Google Scholar
|
|
17
|
Gregorio CC, Weber A, Bondad M, Pennise CR
and Fowler VM: Requirement of pointed-end capping by tropomodulin
to maintain actin filament length in embryonic chick cardiac
myocytes. Nature. 377:83–86. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsukada T, Kotlyanskaya L, Huynh R, Desai
B, Novak SM, Kajava AV, Gregorio CC and Kostyukova AS:
Identification of residues within tropomodulin-1 responsible for
its localization at the pointed ends of the actin filaments in
cardiac myocytes. J Biol Chem. 286:2194–2204. 2011. View Article : Google Scholar :
|
|
19
|
Fowler VM, Greenfield NJ and Moyer J:
Tropomodulin contains two actin filament pointed end-capping
domains. J Biol Chem. 278:40000–40009. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Greenfield NJ, Kostyukova AS and
Hitchcock-DeGregori SE: Structure and tropomyosin binding
properties of the N-terminal capping domain of tropomodulin 1.
Biophys J. 88:372–383. 2005. View Article : Google Scholar
|
|
21
|
Kostyukova AS, Choy A and Rapp BA:
Tropomodulin binds two tropomyosins: A novel model for actin
filament capping. Biochemistry. 45:12068–12075. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kostyukova AS, Rapp BA, Choy A, Greenfield
NJ and Hitchcock-DeGregori SE: Structural requirements of
tropomodulin for tropomyosin binding and actin filament capping.
Biochemistry. 44:4905–4910. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ito-Kureha T, Koshikawa N, Yamamoto M,
Semba K, Yamaguchi N, Yamamoto T, Seiki M and Inoue J: Tropomodulin
1 expression driven by NF-κB enhances breast cancer growth. Cancer
Res. 75:62–72. 2015. View Article : Google Scholar
|
|
24
|
Agnelli L, Mereu E, Pellegrino E, Limongi
T, Kwee I, Bergaggio E, Ponzoni M, Zamò A, Iqbal J, Piccaluga PP,
et al; European T-Cell Lymphoma Study Group. Identification of a
3-gene model as a powerful diagnostic tool for the recognition of
ALK-negative anaplastic large-cell lymphoma. Blood. 120:1274–1281.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kasamatsu A, Uzawa K, Nakashima D, Koike
H, Shiiba M, Bukawa H, Yokoe H and Tanzawa H: Galectin-9 as a
regulator of cellular adhesion in human oral squamous cell
carcinoma cell lines. Int J Mol Med. 16:269–273. 2005.PubMed/NCBI
|
|
26
|
Endo Y, Uzawa K, Mochida Y, Shiiba M,
Bukawa H, Yokoe H and Tanzawa H: Sarcoendoplasmic reticulum
Ca2+ ATPase type 2 downregulated in human oral squamous
cell carcinoma. Int J Cancer. 110:225–231. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sakuma K, Kasamatsu A, Yamatoji M, Yamano
Y, Fushimi K, Iyoda M, Ogoshi K, Shinozuka K, Ogawara K, Shiiba M,
et al: Expression status of Zic family member 2 as a prognostic
marker for oral squamous cell carcinoma. J Cancer Res Clin Oncol.
136:553–559. 2010. View Article : Google Scholar
|
|
28
|
Yamatoji M, Kasamatsu A, Kouzu Y, Koike H,
Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K:
Dermatopontin: A potential predictor for metastasis of human oral
cancer. Int J Cancer. 130:2903–2911. 2012. View Article : Google Scholar
|
|
29
|
Pindborg J, Reichart P, Smith C and Van
der Waal I: Histological Typing of Cancer and Precancer of the Oral
Mucosa. 2nd edition. Springer-Verlag; Berlin: 1997, View Article : Google Scholar
|
|
30
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours. 7th edition. John Wiley
& Sons; 2011
|
|
31
|
Shimizu F, Shiiba M, Ogawara K, Kimura R,
Minakawa Y, Baba T, Yokota S, Nakashima D, Higo M, Kasamatsu A, et
al: Overexpression of LIM and SH3 protein 1 leading to accelerated
G2/M phase transition contributes to enhanced tumourigenesis in
oral cancer. PLoS One. 8:e831872013. View Article : Google Scholar
|
|
32
|
Iyoda M, Kasamatsu A, Ishigami T,
Nakashima D, Endo-Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and
Uzawa K: Epithelial cell transforming sequence 2 in human oral
cancer. PLoS One. 5:e140822010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Baba T, Sakamoto Y, Kasamatsu A, Minakawa
Y, Yokota S, Higo M, Yokoe H, Ogawara K, Shiiba M, Tanzawa H, et
al: Persephin: A potential key component in human oral cancer
progression through the RET receptor tyrosine
kinase-mitogen-activated protein kinase signaling pathway. Mol
Carcinog. 54:608–617. 2013. View
Article : Google Scholar
|
|
34
|
Minakawa Y, Kasamatsu A, Koike H, Higo M,
Nakashima D, Kouzu Y, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H,
et al: Kinesin family member 4A: A potential predictor for
progression of human oral cancer. PLoS One. 8:e859512013.
View Article : Google Scholar
|
|
35
|
Lombardi DP, Geradts J, Foley JF, Chiao C,
Lamb PW and Barrett JC: Loss of KAI1 expression in the progression
of colorectal cancer. Cancer Res. 59:5724–5731. 1999.PubMed/NCBI
|
|
36
|
Shimada K, Uzawa K, Kato M, Endo Y, Shiiba
M, Bukawa H, Yokoe H, Seki N and Tanzawa H: Aberrant expression of
RAB1A in human tongue cancer. Br J Cancer. 92:1915–1921. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kouzu Y, Uzawa K, Koike H, Saito K,
Nakashima D, Higo M, Endo Y, Kasamatsu A, Shiiba M, Bukawa H, et
al: Overexpression of stathmin in oral squamous-cell carcinoma:
Correlation with tumour progression and poor prognosis. Br J
Cancer. 94:717–723. 2006.PubMed/NCBI
|
|
38
|
Maula S-M, Luukkaa M, Grénman R, Jackson
D, Jalkanen S and Ristamäki R: Intratumoral lymphatics are
essential for the metastatic spread and prognosis in squamous cell
carcinomas of the head and neck region. Cancer Res. 63:1920–1926.
2003.PubMed/NCBI
|
|
39
|
Kim SY, Nam SY, Choi SH, Cho KJ and Roh
JL: Prognostic value of lymph node density in node-positive
patients with oral squamous cell carcinoma. Ann Surg Oncol.
18:2310–2317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nicolson GL: Paracrine and autocrine
growth mechanisms in tumor metastasis to specific sites with
particular emphasis on brain and lung metastasis. Cancer Metastasis
Rev. 12:325–343. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thomas GJ, Lewis MP, Hart IR, Marshall JF
and Speight PM: AlphaVbeta6 integrin promotes invasion of squamous
carcinoma cells through up-regulation of matrix
metalloproteinase-9. Int J Cancer. 92:641–650. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ylipalosaari M, Thomas GJ, Nystrom M,
Salhimi S, Marshall JF, Huotari V, Tervahartiala T, Sorsa T and
Salo T: αvβ6 integrin down-regulates the MMP-13 expression in oral
squamous cell carcinoma cells. Exp Cell Res. 309:273–283. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ramos DM, But M, Regezi J, Schmidt BL,
Atakilit A, Dang D, Ellis D, Jordan R and Li X: Expression of
integrin β6 enhances invasive behavior in oral squamous cell
carcinoma. Matrix Biol. 21:297–307. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Su C, Chen Z, Luo H, Su Y, Liu W, Cai L,
Wang T, Lei Y and Zhong B: Different patterns of NF-kappaB and
Notch1 signaling contribute to tumor-induced lymphangiogenesis of
esophageal squamous cell carcinoma. J Exp Clin Cancer Res.
30:852011. View Article : Google Scholar
|
